According to a recent LinkedIn post from Plantible Foods, the company is highlighting growing commercial traction for its lemna-based Rubi Protein and Lemna Leaf Greens ingredients ahead of the Expo West trade show in Anaheim. The post references a recent FDA GRAS “No Questions” letter for Rubi Protein and suggests accelerating adoption across bakery, egg replacement, emulsifier, binder, and nutrition applications.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The LinkedIn post emphasizes lemna (water lentil) as a rapidly growing aquaculture crop that uses less land and water than traditional protein sources, and is produced via a vertically integrated, closed-loop system. It describes Rubi Protein as a RuBisCO-rich leaf protein positioned as a clean-label alternative to eggs and synthetic binders in a range of food formats.
As shared in the post, several partners are expected to feature Rubi-powered products at Expo West, including allergen-free muffins and brownies from Flax4Life, Italian sausage crumbles from ICL Group using Rovitaris, and macarons that are presented as a test of Rubi’s egg-replacement performance. The post also notes plans by wellness brand Mujo to introduce what is described as a lemna-powered protein bar, alongside other customers showcasing nutritional snacks and ingredients using Rubi Protein and Lemna Leaf Greens.
The post indicates that Plantible Foods is expanding production capacity to support what it describes as a growing commercial footprint. For investors, these signals of partner launches, trade show visibility, and regulatory progress could point to early-stage scaling of revenue-generating applications and potential differentiation in the alternative protein segment based on functionality and sustainability claims.
If adoption with co-manufacturers and brands continues to increase, Plantible could enhance its position as a B2B ingredients supplier in clean-label egg replacement and binder markets, which may support longer-term volume growth. However, the post does not provide quantitative details on production scale, pricing, margins, or contracted volumes, so the financial impact and timing of any material revenue contribution remain uncertain.

